Sign up to save your podcasts
Or
Share BioNJ's president and CEO assesses the state of NJ's life sciences industry
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
BioNJ's president and CEO assesses the state of NJ's life sciences industry
Life sciences trade association BioNJ represents more than 400 research-based life sciences organizations across New Jersey, from startups to big biopharmaceutical companies. In this edition of NJBIZ Conversations, BioNJ President and CEO Debbie Hart assesses the state of the industry; explains the importance of projects such as HELIX, HAX and SciTech Scity; and some of the tests the industry will likely face over the next 12 to 18 months.
View all episodes
By njbizLife sciences trade association BioNJ represents more than 400 research-based life sciences organizations across New Jersey, from startups to big biopharmaceutical companies. In this edition of NJBIZ Conversations, BioNJ President and CEO Debbie Hart assesses the state of the industry; explains the importance of projects such as HELIX, HAX and SciTech Scity; and some of the tests the industry will likely face over the next 12 to 18 months.